Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization.
Haisa
M
M
First Department of Surgery, Okayama University Medical School, Japan.
Sakagami
K
K
Matsumoto
T
T
Kawamura
T
T
Uchida
S
S
Fujiwara
T
T
Shiozaki
S
S
Inagaki
M
M
Orita
K
K
D001379:Azathioprine / Q000627:therapeutic use*; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007114:Immunization; D016030:Kidney Transplantation; D007959:Lymphocyte Culture Test, Mixed; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology*; D014019:Tissue Donors; D014184:Transplantation, Homologous
D001379:Azathioprine